1-2 of 2
Betul Gok Yavuz
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety and Efficacy of the Addition of the Protein Translation Inhibitor Omacetaxine to Induction with Cytarabine and Idarubicin in Newly Diagnosed AML

Samin Houshyar, Betul Gok Yavuz, Pritesh Patel, Nadim Mahmud, Karen Sweiss, Irum Khan, Santosh L. Saraf, Damiano Rondelli, Anwar Khan, John G. Quigley
Journal: Blood
Blood (2022) 140 (Supplement 1): 5957–5958.
https://doi.org/10.1182/blood-2022-170100
Published: 2022
Journal Articles

Hematologic Predictors of Outcomes in Patients Undergoing Intensive Induction Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia

Saad Arain, MD, Eshana Shah, MD, Betul Gok Yavuz, MD PhD, Sarah Stettner, Gregory Sampang Calip, PharmD,MPH,PhD, Irum Khan, MD, Pritesh Patel, MB, ChB, John G. Quigley
Journal: Blood
Blood (2020) 136 (Supplement 1): 39–40.
https://doi.org/10.1182/blood-2020-136708
Published: 2020